Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

St Barthlomew's Hospital

1 abstract

Abstract
VELOCITY-Lung: A phase (Ph) 2 study evaluating safety and efficacy of domvanalimab (dom) + zimberelimab (zim) + sacituzumab govitecan (SG), or etrumadenant (etruma) + dom + zim, or etruma + zim in patients (pts) with treatment-naïve metastatic non-small cell lung cancer (mNSCLC).
Org: Virginia Cancer Specialists, Queen Mary Hospital, Chang Gung Medical Foundation-LinKou Branch, Rambam Health Care, St Barthlomew's Hospital,